The burden of primary diseases is substantial, demanding fresh therapeutic strategies. Cellular therapies represent a remarkably exciting avenue, offering the chance to regenerate damaged hepatic tissue and improve clinical outcomes. Currently, research focuses on several approaches, including the introduction of induced pluripotent stem cells dire